KemPharm Dips Despite Positive ADHD Trial Results
KemPharm shares dipped on Monday after the firm announced topline results from its ADHD clinical trial.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 129
Major Biopharma Catalysts on July’s FDA Calendar
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in July.
Biogen Wins Big With Midstage Alzheimer’s Study
Biogen shares jumped early on Friday after the firm, in conjunction with Eisai, announced positive results from a midstage Alzheimer’s study.
Why Zynerba Shares Are Getting Crushed
Zynerba Pharmaceuticals shares were crushed early on Thursday after the company reported topline results from an early stage clinical study.
Clovis Breaks Into Europe With EMA Validation
Clovis Oncology shares saw a bump early on Thursday after the company announced that the European Medicines Agency has validated its application for a Type 2 variation to the marketing authorization for Rubraca.
Why Juniper Pharmaceuticals Shares Jumped
Juniper Pharmaceuticals shares jumped early on Tuesday after the company announced that it would be acquired by Catalent.
Why Nuvectra Is Monday’s Big Biotech Loser
Nuvectra shares were crushed on Monday after the company announced an update on its FDA premarket approval application and its TÃœV SÃœD application for CE Mark in Europe for Virtis.
July Fourth Heat and Your Health
The fireworks may not be all that we see in the sky this Fourth of July as much of the country deals with prolonged and excessive heat due to a "heat dome."
FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date
Merck shares retreated to start off the week despite the announcement of good news from the FDA.
Adamis and Novartis Team Up Against Mylan
Adamis Pharmaceuticals saw its shares shoot up early on Monday after the firm announced a partnership with a subsidiary of Novartis.
Biopharma Companies to Watch This Week
Here are a few biotech and pharmaceutical companies to watch for in the coming week and for the month of July.
Massive Biopharma Movers of the Past Week
A few biopharma stocks made massive runs over the course of this past week, some losing more than half their cap. Not all these moves were negative, but the overall sentiment was negative.
Acceleron Pharma and Celgene Knock It Out of the Park in Late-Stage Trial
Acceleron Pharma and Celgene each saw gains on Friday after they reported results from a late-stage trial.
Dermira Wins Big on FDA Approval
Dermira shares made a solid gain to close out the week after the firm announced a key approval from the FDA for Qbrexza (glycopyrronium) cloth.
Why Gemphire Therapeutics Shares More Than Doubled
Gemphire Therapeutics shares more than doubled early on Thursday after the company announced results from a midstage trial for severe hypertriglyceridemia.